<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02695329</url>
  </required_header>
  <id_info>
    <org_study_id>ORTHO.CR.GK53</org_study_id>
    <nct_id>NCT02695329</nct_id>
  </id_info>
  <brief_title>Vanguard TKA With KneeAlign 2 and Without KneeAlign 2</brief_title>
  <official_title>Randomized Controlled Study Comparing Vanguard With KneeAlign2 Navigational System Versus Vanguard Conventional</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose of this study is to determine the effectiveness of the KneeAlign 2 system in terms of
      precise implant alignment by demonstrating that KneeAlign 2 provides better tibial alignment
      compared to conventional instruments
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Purpose of this study is to determine the effectiveness of the KneeAlign 2 system in terms of
      precise implant alignment by demonstrating that KneeAlign 2 provides better tibial alignment
      compared to conventional instruments.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 24, 2016</start_date>
  <completion_date type="Actual">October 26, 2018</completion_date>
  <primary_completion_date type="Actual">October 3, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of Subjects That Have Alignment Within 2 Degrees From Neutral on Tibia</measure>
    <time_frame>Postoperative 6 months</time_frame>
    <description>Proportion of subjects that have tibial alignment within 2 degrees from neutral and compare the accuracy of tibial component alignment between two groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Tibial Posterior Slope Alignment Within Predetermined Threshold</measure>
    <time_frame>Postoperative 6 months</time_frame>
    <description>Deviation of tibial posterior slope angle from preoperative planned angle (within 2 degrees)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Femoral Varus/Valgus Angle Within Predetermined Threshold</measure>
    <time_frame>Postoperative 6 months</time_frame>
    <description>Deviation of femoral valus/valgus angle from preoperative planned angle (within 2 degrees)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Adverse Events and/or Adverse Device Effects</measure>
    <time_frame>Intra-operative and Post-operative 6 months</time_frame>
    <description>Number of participants, who experience adverse events and/or adverse device effects</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Osteoarthritis, Knee</condition>
  <arm_group>
    <arm_group_label>Vanguard with KneeAlign 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Having total knee arthroplasty surgery with the use of a navigation system KneeAlign 2.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vanguard without KneeAlign 2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Having total knee arthroplasty surgery with the use of conventional surgical instruments, and without a navigation system KneeAlign 2.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>KneeAlign 2</intervention_name>
    <description>Patients suffering non-severe varus deformity Osteoarthritis will be enrolled and randomly assigned into one of two treatment groups. Patients in investigational group will be treated with total knee arthroplasty and the accelerometer-based navigational device. Patients in control group will be treated with total knee arthroplasty with conventional instrumentation.</description>
    <arm_group_label>Vanguard with KneeAlign 2</arm_group_label>
    <other_name>KneeAlign2</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Knee (either unilateral or bilateral) Osteoarthritis (varus deformity only)

          -  Subjects willing to return for follow-up evaluations

        Exclusion Criteria:

          -  Knee degenerative diseases other than Knee Osteoarthritis (such as necrosis /
             Rheumatoid Arthritis)

          -  Severe OA deformation (FTA: &gt;185 degrees or &lt;175 degrees)

          -  Active Infection (or within 6 weeks after infection)

          -  Sepsis

          -  Osteomyelitis

          -  Any type of implant is inserted in the affected side of lower extremity

          -  Hip disease on the affected side

          -  Uncooperative patient or patient with neurologic disorders who are incapable of
             following directions

          -  diagnosed Osteoporosis or Osteomalacia

          -  Metabolic disorders which may impair bone formation

          -  Distant foci of infections which may spread to the implant site

          -  Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram

          -  Vascular insufficiency, muscular atrophy or neuromuscular disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yukihide Minoda</last_name>
    <role>Principal Investigator</role>
    <affiliation>Osaka City University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Osaka City University</name>
      <address>
        <city>Osaka</city>
        <zip>558-0022</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>February 19, 2016</study_first_submitted>
  <study_first_submitted_qc>February 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 1, 2016</study_first_posted>
  <results_first_submitted>June 25, 2019</results_first_submitted>
  <results_first_submitted_qc>September 8, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">October 3, 2019</results_first_posted>
  <last_update_submitted>January 31, 2020</last_update_submitted>
  <last_update_submitted_qc>January 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>navigation system</keyword>
  <keyword>palm-sized</keyword>
  <keyword>total knee arthroplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 20, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/29/NCT02695329/Prot_SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Vanguard With KneeAlign 2</title>
          <description>Having total knee arthroplasty surgery with the use of a navigation system KneeAlign 2.
KneeAlign 2: Patients suffering non-severe varus deformity Osteoarthritis will be enrolled and randomly assigned into one of two treatment groups. Patients in investigational group will be treated with total knee arthroplasty and the accelerometer-based navigational device. Patients in control group will be treated with total knee arthroplasty with conventional instrumentation.</description>
        </group>
        <group group_id="P2">
          <title>Vanguard Without KneeAlign 2</title>
          <description>Having total knee arthroplasty surgery with the use of conventional surgical instruments, and without a navigation system KneeAlign 2.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="45"/>
                <participants group_id="P2" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Poor X-ray quality for measurement</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Vanguard With KneeAlign 2</title>
          <description>Having total knee arthroplasty surgery with the use of a navigation system KneeAlign 2.
KneeAlign 2: Patients suffering non-severe varus deformity Osteoarthritis will be enrolled and randomly assigned into one of two treatment groups. Patients in investigational group will be treated with total knee arthroplasty and the accelerometer-based navigational device. Patients in control group will be treated with total knee arthroplasty with conventional instrumentation.</description>
        </group>
        <group group_id="B2">
          <title>Vanguard Without KneeAlign 2</title>
          <description>Having total knee arthroplasty surgery with the use of conventional surgical instruments, and without a navigation system KneeAlign 2.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="50"/>
            <count group_id="B2" value="50"/>
            <count group_id="B3" value="100"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="50"/>
                    <count group_id="B3" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                    <measurement group_id="B2" value="46"/>
                    <measurement group_id="B3" value="95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="50"/>
                    <count group_id="B3" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="75.8" spread="5.2"/>
                    <measurement group_id="B2" value="74.0" spread="6.6"/>
                    <measurement group_id="B3" value="74.9" spread="6.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="50"/>
                    <count group_id="B3" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="79"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="50"/>
                    <count group_id="B3" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="100"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Japan</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="50"/>
                    <count group_id="B3" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="50"/>
                    <count group_id="B3" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26.3" spread="4.2"/>
                    <measurement group_id="B2" value="27.3" spread="4.3"/>
                    <measurement group_id="B3" value="26.8" spread="4.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>EQ-5D-3L</title>
          <description>Measure Description: EQ-5D is patient reported outcome measure to score patient's health related quality of life with minimum score of -0.111 and maximum score of 1.000.
Higher score means better outcomes.</description>
          <population>Missing data on 6 KneeAlign group patients and 5 Conventional group patients. Failed to answer all questions on the form.</population>
          <units>point</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="44"/>
                    <count group_id="B2" value="45"/>
                    <count group_id="B3" value="89"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.553" spread="0.117"/>
                    <measurement group_id="B2" value="0.582" spread="0.091"/>
                    <measurement group_id="B3" value="0.568" spread="0.105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>KSS-Objective Score</title>
          <description>KSS-Objective score is physician-derived component and allows for more than 100 points in patients with greater than 125° of flexion and a stable painless knee as outlined below. Lowest possible score is 0.
Alignment” has a maximum of 25 points. “Instability” allows a maximum of 25 points.
Joint Motion” allows one point for each 5° of joint motion and allows greater than 25 points for patients with greater than 125° of motion. There are deductions for flexion contracture and extension lag. “Symptoms” category has maximum allowable points 25.
Higher score means better outcomes.</description>
          <population>Missing data on 9 KneeAlign2 patients and on 9 Conventional patients. Failed to obtain data.</population>
          <units>point</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="41"/>
                    <count group_id="B2" value="41"/>
                    <count group_id="B3" value="82"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37.4" spread="19.1"/>
                    <measurement group_id="B2" value="35.9" spread="19.3"/>
                    <measurement group_id="B3" value="36.6" spread="19.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>KSS-Patient Satisfaction</title>
          <description>KSS-Patient Satisfaction is patient-derived score and is a five-question 40-point scale that is collected preoperatively and at each follow-up visit. Lowest possible score is 0.
Higher score means better outcomes.</description>
          <population>Missing data, 5 KneeAlign2 patients and 5 conventional patients. Failed to answer all questions on the form.</population>
          <units>point</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="45"/>
                    <count group_id="B2" value="45"/>
                    <count group_id="B3" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11.2" spread="6.1"/>
                    <measurement group_id="B2" value="13.1" spread="6.0"/>
                    <measurement group_id="B3" value="12.1" spread="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>KSS-Function Score</title>
          <description>KSS-function score is patient-derived score and composed of four subgroups and has a maximum score of 100.
“Walking and Standing” has a maximum value of 30 points, “Standard Activities” has a maximum of 30 points, “Advanced Activities” has a maximum of 25 points and “Discretionary Activities” has a maximum of 15 points.
Lowest possible score is 0. Higher score means better outcomes.</description>
          <population>Missing data on 8 KneeAlign2 patients and 12 Conventional patients. Failed to answer all questions on the form.</population>
          <units>point</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="42"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33.5" spread="16.5"/>
                    <measurement group_id="B2" value="43.6" spread="18.4"/>
                    <measurement group_id="B3" value="38.3" spread="18.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>KSS-Patient Expectation</title>
          <description>KSS-Patient Expectations is patient-derived score and is a three-question fifteen-point scale that is collected pre-operatively and post-operatively. The pre-operative questions reflect the patient’s opinion on the extent to which the patient expects that operation will improve knee pain, and ability to perform activities of daily living and recreational activities. The post-operative questions reflect the extent to which postoperative outcome has met the patient’s pre-operative expectations with respect to pain and function.
The score ranges from 3 to 15. Higher score means better outcomes.</description>
          <population>Missing data on 16 KneeAlign2 patients and 13 conventional patients. Failed to answer all questions on the form</population>
          <units>point</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                    <count group_id="B2" value="37"/>
                    <count group_id="B3" value="71"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9.1" spread="2.1"/>
                    <measurement group_id="B2" value="9.6" spread="2.6"/>
                    <measurement group_id="B3" value="9.3" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Oxford Knee Score</title>
          <description>Patient Reported Outcome specific for knee disease. Score range from 0 to 48. Higher score means better outcome.</description>
          <population>Missing data on 7 KneeAlign2 patients and 3 Conventional patients. Failed to answer all questions on the form.</population>
          <units>point</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="43"/>
                    <count group_id="B2" value="47"/>
                    <count group_id="B3" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20.7" spread="8.0"/>
                    <measurement group_id="B2" value="24.0" spread="7.9"/>
                    <measurement group_id="B3" value="22.4" spread="8.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Proportion of Subjects That Have Alignment Within 2 Degrees From Neutral on Tibia</title>
        <description>Proportion of subjects that have tibial alignment within 2 degrees from neutral and compare the accuracy of tibial component alignment between two groups.</description>
        <time_frame>Postoperative 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vanguard With KneeAlign 2</title>
            <description>Having total knee arthroplasty surgery with the use of a navigation system KneeAlign 2.
KneeAlign 2: Patients suffering non-severe varus deformity Osteoarthritis will be enrolled and randomly assigned into one of two treatment groups. Patients in investigational group will be treated with total knee arthroplasty and the accelerometer-based navigational device. Patients in control group will be treated with total knee arthroplasty with conventional instrumentation.</description>
          </group>
          <group group_id="O2">
            <title>Vanguard Without KneeAlign 2</title>
            <description>Having total knee arthroplasty surgery with the use of conventional surgical instruments, and without a navigation system KneeAlign 2.</description>
          </group>
        </group_list>
        <measure>
          <title>Proportion of Subjects That Have Alignment Within 2 Degrees From Neutral on Tibia</title>
          <description>Proportion of subjects that have tibial alignment within 2 degrees from neutral and compare the accuracy of tibial component alignment between two groups.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>within 2 degrees (success)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="41"/>
                    <measurement group_id="O2" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>outlier (failure)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Tibial Posterior Slope Alignment Within Predetermined Threshold</title>
        <description>Deviation of tibial posterior slope angle from preoperative planned angle (within 2 degrees)</description>
        <time_frame>Postoperative 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vanguard With KneeAlign 2</title>
            <description>Having total knee arthroplasty surgery with the use of a navigation system KneeAlign 2.
KneeAlign 2: Patients suffering non-severe varus deformity Osteoarthritis will be enrolled and randomly assigned into one of two treatment groups. Patients in investigational group will be treated with total knee arthroplasty and the accelerometer-based navigational device. Patients in control group will be treated with total knee arthroplasty with conventional instrumentation.</description>
          </group>
          <group group_id="O2">
            <title>Vanguard Without KneeAlign 2</title>
            <description>Having total knee arthroplasty surgery with the use of conventional surgical instruments, and without a navigation system KneeAlign 2.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Tibial Posterior Slope Alignment Within Predetermined Threshold</title>
          <description>Deviation of tibial posterior slope angle from preoperative planned angle (within 2 degrees)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>within 2 degrees (success)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                    <measurement group_id="O2" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>outlier (failure)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Femoral Varus/Valgus Angle Within Predetermined Threshold</title>
        <description>Deviation of femoral valus/valgus angle from preoperative planned angle (within 2 degrees)</description>
        <time_frame>Postoperative 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vanguard With KneeAlign 2</title>
            <description>Having total knee arthroplasty surgery with the use of a navigation system KneeAlign 2.
KneeAlign 2: Patients suffering non-severe varus deformity Osteoarthritis will be enrolled and randomly assigned into one of two treatment groups. Patients in investigational group will be treated with total knee arthroplasty and the accelerometer-based navigational device. Patients in control group will be treated with total knee arthroplasty with conventional instrumentation.</description>
          </group>
          <group group_id="O2">
            <title>Vanguard Without KneeAlign 2</title>
            <description>Having total knee arthroplasty surgery with the use of conventional surgical instruments, and without a navigation system KneeAlign 2.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Femoral Varus/Valgus Angle Within Predetermined Threshold</title>
          <description>Deviation of femoral valus/valgus angle from preoperative planned angle (within 2 degrees)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>within 2 degrees (success)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="35"/>
                    <measurement group_id="O2" value="28"/>
                  </measurement_list>
                </category>
                <category>
                  <title>outlier (failure)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Adverse Events and/or Adverse Device Effects</title>
        <description>Number of participants, who experience adverse events and/or adverse device effects</description>
        <time_frame>Intra-operative and Post-operative 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vanguard With KneeAlign 2</title>
            <description>Having total knee arthroplasty surgery with the use of a navigation system KneeAlign 2.
KneeAlign 2: Patients suffering non-severe varus deformity Osteoarthritis will be enrolled and randomly assigned into one of two treatment groups. Patients in investigational group will be treated with total knee arthroplasty and the accelerometer-based navigational device. Patients in control group will be treated with total knee arthroplasty with conventional instrumentation.</description>
          </group>
          <group group_id="O2">
            <title>Vanguard Without KneeAlign 2</title>
            <description>Having total knee arthroplasty surgery with the use of conventional surgical instruments, and without a navigation system KneeAlign 2.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Adverse Events and/or Adverse Device Effects</title>
          <description>Number of participants, who experience adverse events and/or adverse device effects</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From surgery to 6 month visit.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Vanguard With KneeAlign 2</title>
          <description>Having total knee arthroplasty surgery with the use of a navigation system KneeAlign 2.
KneeAlign 2: Patients suffering non-severe varus deformity Osteoarthritis will be enrolled and randomly assigned into one of two treatment groups. Patients in investigational group will be treated with total knee arthroplasty and the accelerometer-based navigational device. Patients in control group will be treated with total knee arthroplasty with conventional instrumentation.</description>
        </group>
        <group group_id="E2">
          <title>Vanguard Without KneeAlign 2</title>
          <description>Having total knee arthroplasty surgery with the use of conventional surgical instruments, and without a navigation system KneeAlign 2.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Infection</sub_title>
                <description>Postoperative infection</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Image assessment, which is primary endpoint, was done on 2D x-ray (not based on CT).</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Clinical Affairs Senior Manager</name_or_title>
      <organization>Zimmer Biomet G.K.</organization>
      <phone>+81-6402-6777</phone>
      <email>takahito.nakai@zimmerbiomet.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

